Merck | Kostnadene For Salg



Cost Of Sales Endring Dato
Adidas EUR 3B 142M 2024-12
Adyen EUR 119.59M 54.16M 2024-12
Akzo Nobel EUR 1.59B 8M 2024-12
Alcon AG USD 1.12B 34M 2024-12
Amadeus IT EUR 692.4M 250.6M 2024-12
Amarin USD 26.02M 1.3M 2024-09
AstraZeneca USD 2.72B 263M 2024-12
BASF EUR 11.91B 8M 2024-09
Bayer EUR 5.72B 633M 2024-12
Beiersdorf EUR 1.98B 134M 2024-12
Covestro EUR 3.03B 18M 2024-09
Danone EUR 6.8B 3.32B 2024-12
Fresenius EUR 4.22B 212M 2024-12
Fresenius Medical Care EUR 3.81B 200M 2024-12
Galapagos EUR 112.93M 112.91M 2024-12
Genmab DKK 337M 64M 2024-12
Givaudan CHF 1.05B 936.5M 2024-06
GlaxoSmithKline GBP 2.56B 162M 2024-12
GRIFOLS EUR 1.21B 143.12M 2024-12
Henkel EUR 5.34B 290M 2024-06
Hikma Pharmaceutical USD 813M 39M 2024-06
Infineon EUR 2.08B 259M 2024-12
Linde USD 4.32B 36M 2024-12
Lonza CHF 1.94B 858M 2024-06
Merck EUR 2.12B 3M 2024-09
Novartis USD 3.32B 90M 2024-12
Philips EUR 3.08B 710M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 4.08B 675M 2024-09
UCB EUR 425.5M 479.5M 2024-06



Merck Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.